The mixed-lineage kinase DLK undergoes Src-dependent tyrosine phosphorylation and activation in cells exposed to vanadate or platelet-derived growth factor (PDGF)

Cell Signal. 2009 Apr;21(4):577-87. doi: 10.1016/j.cellsig.2008.12.009. Epub 2008 Dec 25.

Abstract

Some data in the literature suggest that serine/threonine phosphorylation is required for activation of the mixed-lineage kinases (MLKs), a subgroup of mitogen-activated protein kinase kinase kinases (MAPKKKs). In this report, we demonstrate that the MLK family member DLK is activated and concurrently tyrosine-phosphorylated in cells exposed to the protein tyrosine phosphatase inhibitor vanadate. Tyrosine phosphorylation appears crucial for activation as incubation of vanadate-activated DLK molecules with a tyrosine phosphatase substantially reduced DLK enzymatic activity. Interestingly, the effects of vanadate on DLK are completely blocked by treatment with a Src family kinase inhibitor, PP2, or the expression of short hairpin RNA (shRNA) directed against Src. DLK also fails to undergo vanadate-stimulated tyrosine phosphorylation and activation in fibroblasts which lack expression of Src, Yes and Fyn, but reintroduction of wild-type Src or Fyn followed by vanadate treatment restores this response. In addition to vanadate, stimulation of cells with platelet-derived growth factor (PDGF) also induces tyrosine phosphorylation and activation of DLK by a Src-dependent mechanism. DLK seems important for PDGF signaling because its depletion by RNA interference substantially reduces PDGF-stimulated ERK and Akt kinase activation. Thus, our findings suggest that Src-dependent tyrosine phosphorylation of DLK may be important for regulation of its activity, and they support a role for DLK in PDGF signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / metabolism*
  • Becaplermin
  • COS Cells / drug effects
  • COS Cells / enzymology
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Chlorocebus aethiops
  • Cyclosporine / pharmacology
  • Death-Associated Protein Kinases
  • Enzyme Activation / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Mice
  • NIH 3T3 Cells / drug effects
  • NIH 3T3 Cells / enzymology
  • Okadaic Acid / pharmacology
  • Phosphorylation / drug effects
  • Phosphotyrosine / chemistry
  • Platelet-Derived Growth Factor / pharmacology*
  • Protein Processing, Post-Translational / drug effects
  • Protein Tyrosine Phosphatases / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism
  • Proto-Oncogene Proteins c-sis
  • RNA Interference
  • Rats
  • Recombinant Fusion Proteins / physiology
  • Vanadates / pharmacology*
  • src-Family Kinases / metabolism*

Substances

  • Apoptosis Regulatory Proteins
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Recombinant Fusion Proteins
  • Becaplermin
  • Okadaic Acid
  • Phosphotyrosine
  • Vanadates
  • Cyclosporine
  • src-Family Kinases
  • Death-Associated Protein Kinases
  • Proto-Oncogene Proteins c-akt
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Extracellular Signal-Regulated MAP Kinases
  • Protein Tyrosine Phosphatases